OMEZA's OCM will be featured in an approved abstract treating a complex chronic burn patient at Fall SAWC Oct.15-18 in Las Vegas

ConferenceOCMPositive

AI Analysis

Summary

OMEZA's OCM product will be featured in an approved abstract presentation at the Fall SAWC Conference in Las Vegas (October 15-18, 2026), presenting a retrospective observational evaluation of OCM as primary therapy for thermal burn wounds.

Outcome Details

Approved abstract presentation on OCM as primary therapy for thermal burn wounds

Importance:2/10

Sentiment:

0.50

wound careburn treatmentconference presentationretrospective observational study

Read the original article

Published by PR Newswire Pharma on August 31, 2026 11:00 AM

Read Original